What AI says about Medelis

AI summary

Medelis is a specialty contract research organization that focuses on oncology clinical trials and drug development for pharmaceutical and biotechnology sponsors.

AI named Medelis from December 2025 to July 2026.

Questions and answers

QuestionAI picks most

Who are the leading contract research organizations for running oncology clinical trials in Eastern Europe?AI picks OCT Clinical Trials most

Sources AI cites

AI cited medelis.com in these answers, after accellclinical.com, sofpromed.com, and cromospharma.com.

accellclinical.com (opens in a new tab)16%
sofpromed.com (opens in a new tab)16%
cromospharma.com (opens in a new tab)11%
oct-clinicaltrials.com (opens in a new tab)11%
biomapas.com (opens in a new tab)5%

Competitors

AI named Medelis alongside Accell Clinical, Allucent, and Biomapas.

Accell Clinical
Allucent
Biomapas
BiTrial Clinical Research
CRI Anna-Maria Kellen Clinical Accelerator

Know where Medelis stands. Keep up as it changes.

Follow its AI visibility, with a Monday email when something changes.

Track Medelis free